BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19348714)

  • 1. Neurofibromatosis type 1 and associated malignancies.
    Yohay K
    Curr Neurol Neurosci Rep; 2009 May; 9(3):247-53. PubMed ID: 19348714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibromatosis type 1 (NF1): diagnosis and management.
    Ferner RE; Gutmann DH
    Handb Clin Neurol; 2013; 115():939-55. PubMed ID: 23931823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on the central nervous system manifestations of neurofibromatosis type 1.
    Nix JS; Blakeley J; Rodriguez FJ
    Acta Neuropathol; 2020 Apr; 139(4):625-641. PubMed ID: 30963251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline mutations in NF1 and BRCA1 in a family with neurofibromatosis type 1 and early-onset breast cancer.
    Campos B; Balmaña J; Gardenyes J; Valenzuela I; Abad O; Fàbregas P; Volpini V; Díez O
    Breast Cancer Res Treat; 2013 Jun; 139(2):597-602. PubMed ID: 23624750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant pheochromocytoma in a 16-year-old patient with neurofibromatosis type 1.
    Giovannoni I; Callea F; Boldrini R; Inserra A; Cozza R; Francalanci P
    Pediatr Dev Pathol; 2014; 17(2):126-9. PubMed ID: 24555864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurofibromatosis von Recklinghausen type 1 (NF1) - clinical picture and molecular-genetics diagnostic].
    Petrák B; Bendová Š; Lisý J; Kraus J; Zatrapa T; Glombová M; Zámečník J
    Cesk Patol; 2015; 51(1):34-40. PubMed ID: 25671360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1.
    Opocher G; Conton P; Schiavi F; Macino B; Mantero F
    Fam Cancer; 2005; 4(1):13-6. PubMed ID: 15883705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of neurofibromatosis and breast cancer: loss of heterozygosity of NF1 in breast cancer.
    Güran S; Safali M
    Cancer Genet Cytogenet; 2005 Jan; 156(1):86-8. PubMed ID: 15588864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
    Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH
    Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis.
    Xu W; Mulligan LM; Ponder MA; Liu L; Smith BA; Mathew CG; Ponder BA
    Genes Chromosomes Cancer; 1992 Jun; 4(4):337-42. PubMed ID: 1377942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma.
    Lau N; Feldkamp MM; Roncari L; Loehr AH; Shannon P; Gutmann DH; Guha A
    J Neuropathol Exp Neurol; 2000 Sep; 59(9):759-67. PubMed ID: 11005256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibromatosis type 1 (NF1) and associated tumors.
    Rosenbaum T; Wimmer K
    Klin Padiatr; 2014 Nov; 226(6-7):309-15. PubMed ID: 25062113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?
    Van-Gils J; Harambat J; Jubert C; Vidaud D; Llanas B; Perel Y; Lacombe D; Goizet C
    Eur J Med Genet; 2014; 57(11-12):639-42. PubMed ID: 25234363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1.
    McPherson JR; Ong CK; Ng CC; Rajasegaran V; Heng HL; Yu WS; Tan BK; Madhukumar P; Teo MC; Ngeow J; Thike AA; Rozen SG; Tan PH; Lee AS; Teh BT; Yap YS
    Cancer Med; 2015 Dec; 4(12):1871-8. PubMed ID: 26432421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibromatosis: the role of guanosine triphosphatase activating proteins in sensory neuron function.
    Hingtgen CM
    Sheng Li Xue Bao; 2008 Oct; 60(5):581-3. PubMed ID: 18958364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NF1 somatic mutational landscape in sporadic human cancers.
    Philpott C; Tovell H; Frayling IM; Cooper DN; Upadhyaya M
    Hum Genomics; 2017 Jun; 11(1):13. PubMed ID: 28637487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral spinal neurofibromas in patients with neurofibromatosis 1.
    Pascual-Castroviejo I; Pascual-Pascual SI; Viaño J; Velazquez-Fragua R; López-Gutierrez JC
    Brain Dev; 2012 Aug; 34(7):563-9. PubMed ID: 21999966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal cardiomyopathy in neurofibromatosis type I: Novel phenotype and review of the literature.
    Ritter A; Cuddapah S; Degenhardt K; Kasperski S; Johnson MP; O'Connor MJ; Ahrens-Nicklas R
    Am J Med Genet A; 2019 Jun; 179(6):1042-1046. PubMed ID: 30919579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
    Gottfried ON; Viskochil DH; Couldwell WT
    Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple malignancy (NET, GIST and pheochromocytoma) as a first manifestation of neurofibromatosis type-1 in an adult patient.
    Poredska K; Kunovsky L; Prochazka V; Dolina J; Chovancova M; Vlazny J; Andrasina T; Eid M; Jabandziev P; Kysela P; Kala Z
    Diagn Pathol; 2019 Jul; 14(1):77. PubMed ID: 31301733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.